Your browser doesn't support javascript.
loading
Safety of tocilizumab in COVID-19 pregnant women and their newborn: A retrospective study.
Jiménez-Lozano, Inés; Caro-Teller, José Manuel; Fernández-Hidalgo, Nuria; Miarons, Marta; Frick, Marie Antoinette; Batllori Badia, Emma; Serrano, Berta; Parramon-Teixidó, Carlos Javier; Camba-Longueira, Fátima; Moral-Pumarega, Maria Teresa; San Juan-Garrido, Rafael; Cabañas Poy, Maria Josep; Suy, Anna; Gorgas Torner, Maria Queralt.
Afiliação
  • Jiménez-Lozano I; Pharmacy Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Caro-Teller JM; Pharmacy Department. Hospital, Universitario "12 de Octubre", Research Institute 12 de Octubre (i+12, Madrid, Spain.
  • Fernández-Hidalgo N; Pediatric Infectious Diseases and Primary Immunodeficiencies Unit, Pediatrics Department, Vall d´hebron Hospital, Barcelona, Spain.
  • Miarons M; Pharmacy Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Frick MA; Pediatric Infectious Diseases and Primary Immunodeficiencies Unit, Pediatrics Department, Vall d´hebron Hospital, Barcelona, Spain.
  • Batllori Badia E; Unit of perinatal medicine, Obstetric and Gynaecology Department, Hospital Universitario "12 de Octubre", Research Institute 12 de Octubre (i+12, Madrid, Spain.
  • Serrano B; Department of Obstetrics and Gynecology, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Parramon-Teixidó CJ; Pharmacy Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Camba-Longueira F; Department of Neonatology, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Moral-Pumarega MT; Unit of perinatal medicine, Obstetric and Gynaecology Department, Hospital Universitario "12 de Octubre", Research Institute 12 de Octubre (i+12, Madrid, Spain.
  • San Juan-Garrido R; Unit of Infectious Diseases, Hospital Universitario "12 de Octubre", Research Institute 12 de Octubre (i+12, Madrid, Spain.
  • Cabañas Poy MJ; Pharmacy Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Suy A; Department of Obstetrics and Gynecology, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Gorgas Torner MQ; Pharmacy Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
J Clin Pharm Ther ; 46(4): 1062-1070, 2021 Aug.
Article em En | MEDLINE | ID: mdl-33638257
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complicações Infecciosas na Gravidez / Anticorpos Monoclonais Humanizados / Tratamento Farmacológico da COVID-19 Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Female / Humans / Newborn / Pregnancy País/Região como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complicações Infecciosas na Gravidez / Anticorpos Monoclonais Humanizados / Tratamento Farmacológico da COVID-19 Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Female / Humans / Newborn / Pregnancy País/Região como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article